Wesley Bull, PA
Medical · Midlothian, TXNPI 1225469935
Payments from drug & device makers
Across 98 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$277
- LEO Pharma Inc.$251
- AbbVie$230
- Sanofi$172
- Regeneron Healthcare Solutions, Inc.$145
- Sun Pharmaceutical Industries Inc.$133
- plus $765 from 15 others
What the payments were for
- Food & beverage$1,90397%
- Education$693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 16 | $277 |
| LEO Pharma Inc. | 11 | $251 |
| AbbVie | 10 | $230 |
| Sanofi | 8 | $172 |
| Regeneron Healthcare Solutions, Inc. | 8 | $145 |
| Sun Pharmaceutical Industries Inc. | 4 | $133 |
| E.r. Squibb & Sons, L.L.C. | 4 | $91 |
| Arcutis Biotherapeutics, Inc. | 3 | $85 |
| Mayne Pharma Commercial LLC | 7 | $75 |
| Novartis | 4 | $62 |
| Galderma Laboratories, L.p. | 3 | $55 |
| Incyte Corporation | 3 | $53 |
| Organon | 3 | $52 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Journey Medical Corporation | 3 | $47 |
| UCB, Inc. | 1 | $40 |
| Dermavant Sciences, Inc. | 2 | $39 |
| Johnson & Johnson | 2 | $35 |
| Almirall LLC | 1 | $31 |
| Amgen | 1 | $30 |
| Genentech USA, Inc. | 1 | $18 |
How this compares
$1,972 in reported general payments places this provider in the 65th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $177,105 |
| Humira PenAdalimumab | 20 | $130,542 |
| Dupixent PenDupilumab | 11 | $41,972 |
| Clobetasol Propionate | 212 | $8,520 |
| Fluorouracil | 52 | $3,740 |
| Ketoconazole | 141 | $2,419 |
| Triamcinolone Acetonide | 144 | $2,143 |
| Doxycycline Hyclate | 40 | $1,252 |
| Clindamycin Phosphate | 24 | $880 |
| Hydroxyzine Hcl | 73 | $671 |
| Minocycline Hcl | 14 | $436 |
| Hydrocortisone | 65 | $364 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 17 | $344 |
| Terbinafine Hcl | 37 | $334 |
| MethotrexateMethotrexate Sodium | 17 | $325 |
Paid to pharmacies, not to this prescriber.
Other medical in Midlothian
- Nguyet NguyenMidlothian$16K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Courtney AldridgeSan Antonio$129K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.